Publicaciones (101) Publicaciones en las que ha participado algún/a investigador/a

2016

  1. MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling

    Neuropharmacology, Vol. 108, pp. 345-352

  2. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 36, Núm. 3, pp. 596-605

  3. A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease

    Journal of Neurology, Vol. 263, Núm. 7, pp. 1390-1400

  4. A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia

    Schizophrenia Research, Vol. 170, Núm. 1, pp. 1-17

  5. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575

  6. Adolescent Δ 9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats

    Neuropsychopharmacology, Vol. 41, Núm. 5, pp. 1416-1426

  7. Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice

    Molecular Neurobiology, Vol. 53, Núm. 5, pp. 3030-3045

  8. Anaerobic membrane bioreactors—a mini review with emphasis on industrial wastewater treatment: applications, limitations and perspectives

    Desalination and Water Treatment, Vol. 57, Núm. 41, pp. 19062-19076

  9. Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome

    Pharmacology Research and Perspectives, Vol. 4, Núm. 2

  10. Anosmin-1 over-expression increases adult neurogenesis in the subventricular zone and neuroblast migration to the olfactory bulb

    Brain Structure and Function, Vol. 221, Núm. 1, pp. 239-260

  11. Anticancer mechanisms of cannabinoids

    Current Oncology, Vol. 23, pp. S23-S32

  12. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 122, pp. 326-338

  13. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

  14. Bacterial translocation affects intracellular neuroinflammatory pathways in a depression-like model in rats

    Neuropharmacology, Vol. 103, pp. 122-133

  15. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile

    Pharmacological Research, Vol. 110, pp. 205-215

  16. Brain-derived neurotrophic factor Val66met polymorphism and plasma levels in road traffic accident survivors

    Anxiety, Stress and Coping, Vol. 29, Núm. 6, pp. 616-629

  17. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia

    Nature Communications, Vol. 7

  18. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: Role of 5-HT1A receptors

    Neuropharmacology, Vol. 103, pp. 16-26

  19. Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia

    British Journal of Pharmacology, pp. 2069-2079

  20. Chemoproteomic approach to explore the target profile of GPCR ligands: Application to 5-HT1A and 5-HT6 receptors

    Chemistry - A European Journal, Vol. 22, Núm. 4, pp. 1313-1321